Kobayashi Pharmaceutical Forecast, price target & analysts
Kobayashi Pharmaceutical Target price 2025 - Analyst rating & recommendation
Kobayashi Pharmaceutical Classifications & Recommendation:
Kobayashi Pharmaceutical Price Target
| Target Price | JPY5,866.25 |
| Price | JPY5,500.00 |
| Potential |
6.66%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target Kobayashi Pharmaceutical 2026 .
The average Kobayashi Pharmaceutical target price is JPY5,866.25.
This is
6.66%
register free of charge
JPY7,000.00
27.27%
register free of charge
JPY4,900.00
10.91%
register free of charge
|
|
| A rating was issued by 8 analysts: 2 Analysts recommend Kobayashi Pharmaceutical to buy, 6 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Kobayashi Pharmaceutical stock has an average upside potential 2026 of
6.66%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion JPY | 165.60 | 173.23 |
| 4.53% | 4.61% | |
| EBITDA Margin | 19.86% | 16.69% |
| 8.18% | 15.95% | |
| Net Margin | 6.08% | 9.49% |
| 47.10% | 56.11% |
8 Analysts have issued a sales forecast Kobayashi Pharmaceutical 2025 . The average Kobayashi Pharmaceutical sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Kobayashi Pharmaceutical EBITDA forecast 2025. The average Kobayashi Pharmaceutical EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Kobayashi Pharmaceutical Analysts have issued a net profit forecast 2025. The average Kobayashi Pharmaceutical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share JPY | 135.42 | 221.19 |
| 49.50% | 63.34% | |
| P/E | 25.20 | |
| EV/Sales | 2.02 |
4 Analysts have issued a Kobayashi Pharmaceutical forecast for earnings per share. The average Kobayashi Pharmaceutical <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the Kobayashi Pharmaceutical stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Kobayashi Pharmaceutical...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
